Informations générales (source: ClinicalTrials.gov)

NCT04173013 Non disponible
Expanded Access Program Using Uromune for Patients With Recurrent Urinary Tract Infections (rUTI)
Expanded Access
  • Infections bactériennes
  • Maladies transmissibles
  • Cystite
  • Infection
  • Récidive
  • Infections urinaires
Impatients N.V. trading as myTomorrows (Voir sur ClinicalTrials)
29 juin 2024
An Expanded Access Program for UROMUNE® for patients suffering from recurrent/chronic urinary tract infections of diverse etiology. This is for individuals for whom antibiotic therapy has failed, but of consideration in all cases, taking into account antibiotic-induced adverse reactions and increasing antibiotic resistance.
 Voir le détail

Etablissements

Les établissements sans correspondance certaine dans le répertoire FINESS dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données
France - Paris - France Contact (sur clinicalTrials)

Critères

Tous
Inclusion Criteria:

- Patients suffering recurrent urinary tract infections of diverse etiology.


- Individuals being allergic to any of the ingredients of UROMUNE®.

- Pregnancy and breast feeding. There are neither specific studies nor a formal
contraindication, the physician should value benefits/risk.